Cargando…
Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
The novel respiratory virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), emerged during late 2019 and spread rapidly across the world. It is now recognised that the nervous system can be affected in COVID-19, with several studies rep...
Autores principales: | Collier, Mary EW, Zhang, Shaowei, Scrutton, Nigel S, Giorgini, Flaviano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889466/ https://www.ncbi.nlm.nih.gov/pubmed/33609782 http://dx.doi.org/10.1016/j.drudis.2021.02.009 |
Ejemplares similares
-
Structural basis of kynurenine 3-monooxygenase inhibition
por: Amaral, Marta, et al.
Publicado: (2013) -
Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane
por: Swaih, Aisha M., et al.
Publicado: (2022) -
A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics
por: Maddison, Daniel C., et al.
Publicado: (2020) -
A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites
por: Zhang, Shaowei, et al.
Publicado: (2019) -
Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma
por: Sathyasaikumar, Korrapati V., et al.
Publicado: (2022)